The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
- 1 May 2001
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 22 (5) , 269-276
- https://doi.org/10.1016/s1471-4906(01)01896-8
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998
- DNA VaccinesCritical Reviews in Immunology, 1998
- A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck CarcinomaThe Journal of Experimental Medicine, 1997
- Immunotherapy for CancerScientific American, 1996
- Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.The Journal of Experimental Medicine, 1996
- A unique tumor antigen produced by a single amino acid substitutionImmunity, 1995
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- A pigmentation‐associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serumInternational Journal of Cancer, 1983